The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

US health officials are reportedly reexamining a $590 million agreement awarded to Moderna (Nasdaq: MRNA) for the development ...

U.S. officials are reportedly considering pulling the plug on a $590 million contract awarded to Moderna to develop a bird ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

U.S. health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock ...

The U.S. Centers for Disease Control and Prevention and the Food and Drug Administration took part in a World Health ...

The latest actions by federal health authorities overseen by Robert F. Kennedy Jr. on vaccine development and evaluation are ...

The Trump administration is reconsidering a $590 million human bird flu vaccine contract with Moderna. ( The Hill) Over 40% ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Each year, flu vaccines are tailored to match the most prevalent virus strains expected to circulate. Without an official ...